CMND — Clearmind Medicine Balance Sheet
0.000.00%
Last trade - 00:00- $5.18m
- -$0.69m
Annual balance sheet for Clearmind Medicine, fiscal year end - October 31st, USD millions except per share, conversion factor applied.
2020 October 31st | 2021 October 31st | R2022 October 31st | 2023 October 31st | 2024 October 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | Interim Report | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | fx Final | fx Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 0.248 | 3.71 | 0.323 | 5.51 | 6.86 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.002 | 0.13 | 0.098 | 0.24 | 0.181 |
| Prepaid Expenses | |||||
| Total Current Assets | 0.25 | 3.97 | 0.435 | 5.79 | 7.09 |
| Net Property, Plant And Equipment | 0.135 | 0.017 | 0.049 | 0.002 | 0.052 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 0.385 | 4.16 | 0.826 | 5.95 | 7.26 |
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.01 | 0.288 | 1.93 | 4.97 | 4.13 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.01 | 0.288 | 1.93 | 4.97 | 4.15 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 0.375 | 3.88 | -1.11 | 0.983 | 3.11 |
| Total Liabilities & Shareholders' Equity | 0.385 | 4.16 | 0.826 | 5.95 | 7.26 |
| Total Common Shares Outstanding |